FAM167B Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-57162
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: PSYLEWTAQVQSQAWRRAQAKPGPGGPGDICGFDSMDSALEWLRRELREM
Reactivity Notes
Mouse 84%, Rat 84%
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for FAM167B Antibody
Immunocytochemistry/ Immunofluorescence: FAM167B Antibody [NBP2-57162]
Immunocytochemistry/Immunofluorescence: FAM167B Antibody [NBP2-57162] - Staining of human cell line BJ shows localization to actin filaments.Applications for FAM167B Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
ICC/IF,Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: FAM167B
Alternate Names
C1orf90, chromosome 1 open reading frame 90, family with sequence similarity 167, member B, hypothetical protein LOC84734, MGC10820
Gene Symbol
FAM167B
Additional FAM167B Products
Product Documents for FAM167B Antibody
Product Specific Notices for FAM167B Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...